South American Gold Overview
Valuation check: SAGD's ROE is 87.84%, above the Healthcare sector average of 21.28%.
Get informed when a big investor buys or sells
+ Follow87.84%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, SAGD shows a ROE of 87.84%. That is above the Healthcare sector average of 21.28%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 21.28%. South American Gold is at 87.84%, which is higher that average. That is roughly 312.8% above the sector mean. Use the comparison chart on this page to see how SAGD stacks up against individual peers as well.
Check the historical chart to see whether SAGD's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare South American Gold with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has South American Gold's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 87.84%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 21.28%, while SAGD is at 87.84%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
